BCR-ABL is responsible for approximately 90% of adult CML, 20% of adult ALL (acute lymphoblastic leukemia) and 2% of adult AML (acute myeloid leukemia) (59). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.